Directorate Change
Updated : 07:00
DRAFT
Redcentric plc
("Redcentric" or the "Company")
Directorate Change
Redcentric plc (AIM: RCN), a leading UK IT managed services provider, is pleased to announce that Alan Aubrey will join the board of directors of the Company (the "Board") as non-executive director. Alan's appointment will be effective from the announcement of the Company's preliminary results for the financial year ended 31 March 2022, expected to be on 21 July 2022. The Company also announces that Jon Kempster, current chair of the Company's Audit Committee, intends to step down from the Board on announcement of the Company's preliminary results. Alan will take over as chair of the Company's Audit Committee and Senior Independent Director from the same date and also be a member of the Company's Remuneration and Nomination Committees.
Alan is an experienced executive and non-executive director, having been CEO of IP Group plc from 2006 to 2021 and having served as non-executive chair of Ceres Power Holdings plc and Proactis Holdings plc and non-executive director in Avacta Group plc. Alan has also served on the boards of several, large private companies including Oxford Nanopore, Ceres Power and Oxford Sciences Innovation plc and previously served as a non-executive director and chaired the audit committee of the Department of Business, Innovation, University and Skills ('DIUS', now the Department for Business, Energy & Industrial Strategy 'BEIS') of the UK government. Alan is a qualified chartered accountant.
Nick Bate, non-executive chair, commented:
"I am delighted that Alan will be joining the Board of Redcentric and we all look forward to working with him. His breadth and depth of skills and experience will be of huge value to the Board as well as the audit committee, and his market knowledge will be of great benefit to Redcentric."
As required under Schedule Two, paragraph (g) of the AIM Rules for Companies, further disclosures on Mr Aubrey are as follows:
Mr Alan John Aubrey, aged 61, has held the following directorships and/or partnerships in the past five years:
Current directorships and/or partnerships:
· IP2IPO Services Limited
· Trellix Limited
· Rio Al Limited
· EUREKA! THE NATIONAL CHILDREN'S MUSEUM.
Past directorships and/or partnerships:
· Top Technology Ventures Limited | · IP Assist Services Limited |
· IP2IPO Asia-Pacific Limited | · IP2IPO Innovations Limited |
· IP2IPO Limited | · LifeUK (IP2IPO) Limited |
· IP Venture (Scotland) Limited | · IP Industry Partners Limited |
· IP2IPO ANZ Carry Limited | · Avacta Group Plc |
· IP Group Plc | · MOBILIOn Inc |
· Oxford Nanopore Technologies Plc | · IP2IPO Guarantee Limited |
· Oxford Science Enterprises Plc | · IP2IPO Management VI Limited |
· Proactis Holdings Plc | · IP2IPO Management V Limited |
· Ceres Power Intermediate Holdings Limited | · IP2IPO (Europe) Limited |
· Ceres Power Holdings Plc | · IP2IPO Management IV Limited |
· North East Technology (GP) Limited | · IP Venture Fund (GP) Limited |
· Touchstone Innovations Limited | · IP2IPO Management II Limited |
· IP2IPO Company Maker Limited | · IP2IPO Management Limited |
· IP2IPO US Partners Limited | · Innovations Limited Partner Ltd |
· IP2IPO Americas Limited | · Touchstone Innovations Investments Limited |
Mr Aubrey holds 8,257 ordinary shares representing 0.005% of the total voting rights in the Company.
There is no further information on Mr Aubrey required to be disclosed under Schedule Two, paragraph (g) of the AIM Rules for Companies.
Enquiries:
Redcentric plc Peter Brotherton, Chief Executive Officer David Senior, Chief Financial Officer
| +44 (0)800 983 2522 |
finnCap Ltd - Nomad and Sole Broker Marc Milmo / Simon Hicks / Charlie Beeson (Corporate Finance) Andrew Burdis / Sunila de Silva (ECM) | +44 (0)20 7220 0500 |
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.